Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

CAMBRIDGE, Mass. - Wave Life Sciences Ltd . (NASDAQ:WVE), a clinical-stage biotechnology company with a market capitalization of $1.87 billion, has announced the commencement of its Phase 1 INLIGHT ...

SBI Q3 Results LIVE: Capital Adequacy Ratio (CAR) as at the end of Q3FY25 stands at 13.03%, shows an exchange filing. - Credit growth at 13.49% YoY with domestic advances growing by 14.06% YoY.

Q3 Earnings Today: While a number of companies across industries have already released their Q3 results, many others are still in queue and the earnings season is going on in full swing. Till date ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

Follow our LIVE blog for the latest updates. We wrap up today's edition of the Moneycontrol live Q3 earnings blog, and will be back tomorrow morning with all the latest updates and alerts.

Several companies are announcing their results for the October-December quarter of the current financial year (FY25). Follow our LIVE blog for the latest updates. Around 174 companies are set to ...

Q3 Results, Earnings Today: Today, companies like Swiggy, Reliance Power, Page Industries, Kansai Nerolac Paints, Arvind Fashions, and several others are releasing their Q3 numbers. (Image Source ...

Fourth Quarter and Full Year 2024 Net Product Sales of $615 Million and $2.3 Billion, Representing Year-Over-Year Growth of 23% and 26% Respectively INGREZZA® (valbenazine) Full Year 2025 Net Product ...

Takeda has officially taken over Shire in a deal that could re-establish the trend for mega mergers in big pharma. The merger was approved yesterday in a court hearing in Jersey, where Shire was ...